Prothena
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Prothena and other ETFs, options, and stocks.About PRTA
Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases.
CEOGene G. Kinney
CEOGene G. Kinney
Employees163
Employees163
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2012
Founded2012
Employees163
Employees163
PRTA Key Statistics
Market cap479.36M
Market cap479.36M
Price-Earnings ratio-1.71
Price-Earnings ratio-1.71
Dividend yield—
Dividend yield—
Average volume486.91K
Average volume486.91K
High today$9.35
High today$9.35
Low today$8.67
Low today$8.67
Open price$9.15
Open price$9.15
Volume582.59K
Volume582.59K
52 Week high$16.67
52 Week high$16.67
52 Week low$4.32
52 Week low$4.32
Stock Snapshot
The current Prothena(PRTA) stock price is $8.74, with a market capitalization of 479.36M. The stock trades at a price-to-earnings (P/E) ratio of -1.71.
As of 2026-01-12, Prothena(PRTA) stock has fluctuated between $8.67 and $9.35. The current price stands at $8.74, placing the stock +0.8% above today's low and -6.5% off the high.
The Prothena(PRTA)'s current trading volume is 582.59K, compared to an average daily volume of 486.91K.
In the last year, Prothena(PRTA) shares hit a 52-week high of $16.67 and a 52-week low of $4.32.
In the last year, Prothena(PRTA) shares hit a 52-week high of $16.67 and a 52-week low of $4.32.
Analyst ratings
57%
of 7 ratingsBuy
57.1%
Hold
28.6%
Sell
14.3%
People also own
Based on the portfolios of people who own PRTA. This list is generated using Robinhood data, and it’s not a recommendation.